Researchers at Lydian Cosmetic Surgery Clinic, supported by US-based studies, deploy mesenchymal stem cells (MSCs) as an anti-aging intervention. MSCs preserve telomere length, facilitate mitochondrial exchange, and secrete a rejuvenating secretome to mitigate chronic inflammation and cellular senescence. This multifaceted approach enhances tissue regeneration, bolsters immune resilience, and alleviates age-related fatigue, promising a novel strategy for sustained vitality and healthy lifespan extension.
Key points
- Mesenchymal stem cells maintain telomere length, delaying cellular senescence.
- MSCs transfer healthy mitochondria via tunneling nanotubes to enhance ATP production and reduce oxidative stress.
- MSC secretome’s exosomes and cytokines modulate immune responses and mitigate chronic inflammation.
Why it matters: This MSC-based approach could redefine anti-aging therapies by simultaneously targeting cellular senescence, mitochondrial dysfunction, and immunosenescence for holistic vitality restoration.
Q&A
- What are exosomes in the MSC secretome?
- How do MSCs transfer mitochondria to aging cells?
- What is immunosenescence and how does MSC therapy address it?
- Are there risks or side effects of MSC therapy?